Mechanisms of sulbactam-durlobactam resistance in Acinetobacter baumannii
Yu Feng1, Laurent Poirel2, Zhiyong Zong1
1Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China.
Abstract:
Sulbactam-durlobactam is the first-line agent against carbapenem-resistant Acinetobacter baumannii. Resistance can be conferred by metallo-β-lactamases alone or penicillin-binding protein 3 alterations plus β-lactamase overproduction or enhanced efflux. Other reported mechanisms remain associative and resistance in guideline-recommended carbapenem addition is unclear, underscoring the need for mechanistic validation and further studies.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...

